Petrolatum / zinc oxide Topical Product
RxNorm 1156405

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1156405 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: petrolatum / zinc oxide Topical Product.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCDG
Petrolatum / zinc oxide Topical Product
AUI:12294430
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDGPrescribable

Semantic Clinical Dose Form Group (SCDG):
Petrolatum / zinc oxide Topical Product
(Atom ID: 12294430)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
petrolatum / zinc oxide Topical Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1156405
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12294430
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCDG
Semantic Clinical Dose Form Group (Ingredient + Dose Form Group)
Source Code
1156405
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AVAILABLE STRENGTH
0.49 MG/MG / 0.15 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.5 MG/MG / 0.16 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.715 MG/MG / 0.01 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.785 MG/MG / 0.08 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.78 MG/MG / 0.076 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.87 MG/MG / 0.088 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
300 MG/ML / 100 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
490 MG/ML / 150 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
780 MG/ML / 100 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
780 MG/ML / 200 MG/ML
Available drug strengths listed in the order of ingredients from the drug